Trevi Therapeutics, Inc. (TRVI)
NASDAQ: TRVI · Real-Time Price · USD
13.43
-0.77 (-5.42%)
At close: May 18, 2026, 4:00 PM EDT
13.24
-0.19 (-1.41%)
Pre-market: May 19, 2026, 7:00 AM EDT
Trevi Therapeutics Stock Forecast
Stock Price Forecast
According to 11 analysts polled by S&P Global, Trevi Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $23.45. The average 1-year stock price forecast is 74.61% higher than the current stock price, while the lowest is $19 (+41.47%) and the highest is $30 (+123.38%).
Price Target: $23.45 (+74.61%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Trevi Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 8 | 8 | 9 | 7 | 7 |
| Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 12 | 12 | 13 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $21 | Strong Buy | Reiterates | $21 | +56.37% | May 6, 2026 |
| Needham | Needham | Strong Buy Maintains $24 → $23 | Strong Buy | Maintains | $24 → $23 | +71.26% | May 6, 2026 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $19 | Strong Buy | Maintains | $19 | +41.47% | Apr 17, 2026 |
| Jones Trading | Jones Trading | Strong Buy Maintains $25 → $24 | Strong Buy | Maintains | $25 → $24 | +78.70% | Mar 19, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $19 → $18 | Buy | Maintains | $19 → $18 | +34.03% | Mar 18, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.46
from -0.32
EPS Next Year
-0.62
from -0.46
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | n/a | n/a | ||||||
| Avg | n/a | n/a | ||||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -0.23 | -0.18 | ||||||
| Avg | -0.46 | -0.62 | ||||||
| Low | -0.59 | -0.97 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.